BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6277133)

  • 1. Interaction of prostaglandin and cyclic AMP involved in regulation of platelet function.
    Kimura Y; Yasunaga K
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1130-8. PubMed ID: 6277133
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 4. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin decreases platelet cyclic AMP in the absence of prostaglandin synthesis.
    Lagarde M; Dechavanne M
    Biomedicine; 1977 Apr; 27(3):110-2. PubMed ID: 196696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of blood platelet function by cyclic nucleotides.
    Haslam RJ; Davidson MM; Davies T; Lynham JA; McClenaghan MD
    Adv Cyclic Nucleotide Res; 1978; 9():533-52. PubMed ID: 208396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of glucose and glycogen metabolism for platelet function.
    Schneider W; Gear AR
    Ciba Found Symp; 1975; 35():225-38. PubMed ID: 179767
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
    Salzman EW; Lindon JN; Rodvien R
    J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present status and prospects of platelet inhibitors].
    Yasunaga K
    Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of prostaglandins E1, I2 and F2 alpha on the shape and phosphatidylinositol-4,5-bisphosphate metabolism of washed rabbit platelets.
    Vickers JD; Kinlough-Rathbone RL; Mustard JF
    Thromb Res; 1982 Dec; 28(6):731-40. PubMed ID: 6301091
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
    Ashby B
    Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of PGI2 and di-butyryl cyclic-AMP on platelets exposed to shear stress.
    Hardwick RA; Hellums JD; Peterson DM; Moake J; Olson J
    Trans Am Soc Artif Intern Organs; 1981; 27():192-6. PubMed ID: 6277071
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP and platelet function.
    Salzman EW
    N Engl J Med; 1972 Feb; 286(7):358-63. PubMed ID: 4333462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.